Celonic AG is a privately owned CDMO based in Basel, Switzerland, providing comprehensive GMP development and manufacturing services for New Biological Entities (NBEs) and Biosimilars worldwide.
Celonic’s services include the development of cell lines, production processes, as well as the GMP and non-GMP manufacturing of biopharmaceutical drug substances. In addition, Celonic licenses its proprietary CHOvolution™ cell line technology to clients, drug developers and service providers.
Applying empathy, efficiency and excellence, Celonic goes one step beyond expectations in all business aspects in order to help its clients attain their goals more efficiently and reliably.
Being part of the JRS Pharma family, Celonic is a strong believer in creating win-win value propositions for its clients, mitigations risks by mutually-beneficial business models.
Visit Celonic website http://www.celonic.com/ to learn more.